Pharma Friday – September 4, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer On August 26, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients […]
The post Pharma Friday – September 4, 2026 appeared first on Endocrine News.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
